Navigation Links
Blood pressure control with ACE inhibitor or diuretic?

An Australian study published in The New England Journal of Medicine has challenged the American ALLHAT trial that showed diuretics were superior to ACE (angiotensin-converting enzyme) inhibitors and calcium channel blockers in controlling blood pressure. The Australian study included 6,083 people who were mostly white. Blood pressure reduction was the same in those who took a diuretic and those who took an ACE inhibitor. The incidence of stroke was the same in both// groups, but the number of deaths from cardiovascular disease was 11 percent lower in the ACE inhibitor group.

Study author Dr. Christopher M. Reid of the Baker Heart Institute in Melbourne said that the differing results could have been due to the difference in the ethnic makeup of the two trials. He explained that thirty percent of the ALLHAT subjects were black Americans, who are known not to respond to ACE inhibitors, while the Australian study comprised mostly of whites. However, he also added that for most patients the conflicting results of the two trials will not make much difference, and that almost all people with high blood pressure need to take more than one drug. Reid said that their study recommended starting with an ACE inhibitor and then using a diuretic, if one is over the age of 65, while the ALLHAT study recommended starting with a diuretic and then adding a calcium channel blocker or an ACE inhibitor. Reid concluded that further research will lead to a situation where there will be specific recommendations for various groups of patients like the elderly, the diabetics, and the ethnic groups. He also stated that irrespective of the studies, the choice of agent that best suits the patient and the agent with which they are most compliant and comfortable would be the agent of choice.


'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... (MRE), is pleased to be invited to the Siemens Healthineers annual customer education ... The event will take place from March 27 - 31, 2017 at ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... all holidays (IBT World Travel Trends Report). As travelers visit both urban destinations, ... in temperatures, and prolonged sun exposure. In response, the outdoor industry has blurred ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... society dedicated to advancing the science and clinical practice of radiosurgery, announced ... Patient Registry, a multi-institutional, observational registry established to standardize data collection from ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., ... (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products ... first of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017  Rosen Law Firm, a global investor ... action lawsuit on behalf of purchasers of Kitov Pharmaceutical ... and/or traceable to Kitov,s initial public offering on or ... open market from November 20, 2015 through February 3, ... seeks to recover damages for Kitov investors under the ...
(Date:3/28/2017)... March 29, 2017 Center Point ... CRO platform, announced today study results presented in ... Pharmacy, #AMCP2017, Managed Care and Specialty Pharmacy annual ... Data in both posters demonstrated that pharmacist-led patient interventions ... adherence. These factors are crucial to generating the robust ...
(Date:3/28/2017)... and TEL AVIV, Israel , March ... subsidiary in Israel . This new business entity, ... be mostly dedicated to research and development of novel assays complementing ... will also, when relevant, locally support commercialization and sales development of ... This ...
Breaking Medicine Technology: